Oncosec Medical reports plans for public sale of common share units

Deal funds clinical trials, working capital and corporate purposes

By Devika Patel

Knoxville, Tenn., Aug. 24 - Oncosec Medical Inc. plans to price a public offering of units with a 45-day greenshoe, according to a Form S-1 filed Friday with the Securities and Exchange Commission.

The company will sell units of a common share and warrants.

Proceeds will be used to pay amounts owed to Inovio, for clinical trials, working capital and general corporate purposes.

The company's stock (OTCBB: ONCS) closed at $0.20 per share on Aug. 22.

The biomedical company is based in San Diego.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.